Navitoclax (ABT-263) Rejuvenates Human Skin by Eliminating Senescent Dermal Fibroblasts in a Mouse/Human Chimeric Model
- 1 February 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Rejuvenation Research
- Vol. 26 (1), 9-20
- https://doi.org/10.1089/rej.2022.0048
Abstract
Chronic senescence, such as aging, contributes to age-related tissue dysfunction and disease development. The accumulation of senescent fibroblasts and the senescence-associated secretory phenotype are particularly implicated in this process. Removal of senescent cells has been reported to prevent tissue dysfunction and extend life span during aging. ABT-263 (navitoclax), which inhibits antiapoptotic proteins, is a leading antiaging drug; however, its role in human skin aging is unclear. This study aimed to determine the rejuvenating effects of ABT-263 on aging skin using a human skin graft mouse model. We assessed the viability of ABT-263-treated skin fibroblasts after inducing senescence. Aged human skin was transplanted under the back skin of nude mice and injected intraperitoneally with the drug or control. Analysis of the skin specimens revealed that ABT-263 induced selective elimination of senescent dermal fibroblasts. Senescent human skin treated with ABT-263 exhibited a decrease in the number of senescent cells and in the expression of aging-related secretory phenotype molecules, such as matrix metalloproteinases and interleukins and an increase in collagen density. Our results indicate that selective removal of senescent skin cells with ABT-263 can improve the aging phenotype of human skin without side effects. ABT-263 is, thus, a novel potential therapeutic agent for skin aging.Keywords
This publication has 37 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Inflammatory networks during cellular senescence: causes and consequencesTrends in Molecular Medicine, 2010
- The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor SuppressionAnnual review of pathology, 2010
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer TherapyClinical Cancer Research, 2009
- Aging Alters Functionally Human Dermal Papillary Fibroblasts but Not Reticular Fibroblasts: A New View of Skin Morphogenesis and AgingPLOS ONE, 2008
- Bcl-2 inhibitors: small molecules with a big impact on cancer therapyCell Death & Differentiation, 2008
- Decreased Collagen Production in Chronologically Aged Skin: Roles of Age-Dependent Alteration in Fibroblast Function and Defective Mechanical StimulationThe American Journal of Pathology, 2006
- Cellular Senescence in Aging PrimatesScience, 2006
- The Role of Cellular Senescence in Skin AgingJournal of Investigative Dermatology, 1998
- Telomeres shorten during ageing of human fibroblastsNature, 1990